MGRX Mangoceuticals Inc

$MGRX this is looking like its heading to dollars again see chart did it now to long same chart signals going off again

$MGRX perking here awaiting a new business combo to replace the one that was terminated move to over $1 when it came out

$MGRX added a few more , compliance til Feb 2027, after the failed business combo -Nuclea deal , actively seeking another one. Ran to 1.25 in late July, so probably similar when another combo is announced

$MGRX detailed a $0.75 per share securities offering of 657,000 common shares and warrants, raising about $492,750.

$MGRX perking here last news "Mangoceuticals Secures $2.5 Million Strategic Investment in MangoRx IP Holdings; Receives Initial $1.75 Million Tranche" perhaps they will have the $$$ now for another business combo

$MGRX According to Mangoceuticals’ annual SEC filings, the company closed 2025 with 15,487,487 common shares outstanding and a total stockholders' equity of $3,281,495 [MGRX 10-K Dec 31 2025]. However, during the first half of 2026, the company ballooning the share count to 29,548,726 shares by June 30, 2026 [MGRX 10-Q June 30 2026]. Assuming no further shares are issued in H2 2026 the evaluation of Book Value per Share (BVPS) Year-End 2026 with shareholders' equity of $ 5,537,482 projected Your true intrinsic book value per share drops from $0.21 to $0.19 (an 11.4% destruction in per-share value). This BVPS proves why the market is currently pricing the stock not at least for 10 Trading sessions in a row above the minimum required $ 1 for NASDAQ compliant listing. The stock trades at a premium around 100 to 150 % to its tangible book value because investors are waiting to see if the company can actually commercialize the remaining 75% of the patent asset before the cash runs dry again.

$MGRX back in on the late dump today, TY. 90k at .40. Let the fed give me those 36s I been waiting on for 2 months plz